143 related articles for article (PubMed ID: 35332289)
41. Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab.
Talks SJ; Bhatia D; Menon G; Cole A; Eleftheriadis H; Downey L; Chong NV; Sivaprasad S;
Eye (Lond); 2019 Jun; 33(6):930-937. PubMed ID: 30728488
[TBL] [Abstract][Full Text] [Related]
42. Analysis of retinal layer thickness in diabetic macular oedema treated with ranibizumab or triamcinolone.
Prager SG; Lammer J; Mitsch C; Hafner J; Pemp B; Scholda C; Kundi M; Schmidt-Erfurth U; Kriechbaum K
Acta Ophthalmol; 2018 Mar; 96(2):e195-e200. PubMed ID: 29063703
[TBL] [Abstract][Full Text] [Related]
43. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
[TBL] [Abstract][Full Text] [Related]
44. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
[TBL] [Abstract][Full Text] [Related]
45. Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study).
Ehrlich R; Pokroy R; Segal O; Goldstein M; Pollack A; Hanhart J; Barak Y; Kehat R; Shulman S; Vidne O; Abu Ahmad W; Chowers I
Eur J Ophthalmol; 2019 Mar; 29(2):229-233. PubMed ID: 29916263
[TBL] [Abstract][Full Text] [Related]
46. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
[TBL] [Abstract][Full Text] [Related]
47. Refractive changes after intravitreal ranibizumab injections for diabetic macular oedema.
Chatziralli I; Chatzipantelis A; Dimitriou E; Mpourouki E; Theodossiadis G; Theodossiadis P
Clin Exp Optom; 2018 May; 101(3):397-399. PubMed ID: 29134696
[TBL] [Abstract][Full Text] [Related]
48. [Improvement of fixation in diabetic macular oedema patients under intravitreal ranibizumab treatment].
Seidensticker F; Reznicek L; Cserhati S; Liegl RG; Langer J; Wolf A; Kampik A; Ulbig M; Haritoglou C; Kernt M
Klin Monbl Augenheilkd; 2013 May; 230(5):524-9. PubMed ID: 23229224
[TBL] [Abstract][Full Text] [Related]
49. Contribution of ultra-wide field fluorescein angiography in diabetic retinopathy in a Tunisian population.
Maamouri R; Bouraoui R; El Matri K; Chebil A; Hassairi A; Regai E; Falfoul Y; El Matri L
Tunis Med; 2021 Juillet; 99(7):757-763. PubMed ID: 35261008
[TBL] [Abstract][Full Text] [Related]
50. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
[TBL] [Abstract][Full Text] [Related]
51. Ultra-Wide-Field Fluorescein Angiography-Guided Normalization of Ischemic Index Calculation in Eyes With Retinal Vein Occlusion.
Wang K; Ghasemi Falavarjani K; Nittala MG; Sagong M; Wykoff CC; van Hemert J; Ip M; Sadda SR
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3278-3285. PubMed ID: 29971447
[TBL] [Abstract][Full Text] [Related]
52. Peripheral retinal function assessed with 30-Hz flicker seems to improve after treatment with Lucentis in patients with diabetic macular oedema.
Holm K; Schroeder M; Lövestam Adrian M
Doc Ophthalmol; 2015 Aug; 131(1):43-51. PubMed ID: 25773362
[TBL] [Abstract][Full Text] [Related]
53. Predictive imaging biomarkers relevant for functional and anatomical outcomes during ranibizumab therapy of diabetic macular oedema.
Gerendas BS; Prager S; Deak G; Simader C; Lammer J; Waldstein SM; Guerin T; Kundi M; Schmidt-Erfurth UM
Br J Ophthalmol; 2018 Feb; 102(2):195-203. PubMed ID: 28724636
[TBL] [Abstract][Full Text] [Related]
54. Microperimetry and mfERG as functional measurements in diabetic macular oedema undergoing intravitreal ranibizumab treatment.
Santos AR; Raimundo M; Alves D; Lopes M; Pestana S; Figueira J; Cunha-Vaz J; Silva R
Eye (Lond); 2021 May; 35(5):1384-1392. PubMed ID: 32616867
[TBL] [Abstract][Full Text] [Related]
55. Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema: A Subanalysis of the RESTORE (Extension) Study.
Karst SG; Deak GG; Gerendas BS; Waldstein SM; Lammer J; Simader C; Guerin T; Schmidt-Erfurth UM
JAMA Ophthalmol; 2018 Apr; 136(4):315-321. PubMed ID: 29494727
[TBL] [Abstract][Full Text] [Related]
56. Decrease in the number of microaneurysms in diabetic macular edema after anti-vascular endothelial growth factor therapy: implications for indocyanine green angiography-guided detection of refractory microaneurysms.
Mori K; Yoshida S; Kobayashi Y; Ishikawa K; Nakao S; Hisatomi T; Haruta M; Isihibashi T; Sonoda KH
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):735-741. PubMed ID: 31960130
[TBL] [Abstract][Full Text] [Related]
57. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
58. Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity.
Busch C; Okada M; Zur D; Fraser-Bell S; Rodríguez-Valdés PJ; Cebeci Z; Lupidi M; Fung AT; Gabrielle PH; Giancipoli E; Chaikitmongkol V; Laíns I; Santos AR; Kunavisarut P; Sala-Puigdollers A; Chhablani J; Ozimek M; Hilely A; Degenhardt V; Loewenstein A; Iglicki M; Rehak M;
Acta Ophthalmol; 2020 Nov; 98(7):e801-e806. PubMed ID: 32115886
[TBL] [Abstract][Full Text] [Related]
59. Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time.
Silva PS; Marcus DM; Liu D; Aiello LP; Antoszyk A; Elman M; Friedman S; Glassman AR; Googe JM; Jampol LM; Martin DF; Melia M; Preston CM; Wykoff CC; Sun JK;
JAMA Ophthalmol; 2022 Oct; 140(10):936-945. PubMed ID: 35980610
[TBL] [Abstract][Full Text] [Related]
60. Correlation between Diabetic Retinopathy Severity and Oxygen Metabolism in Patients with Diabetic Macular Edema during Treatment with Intravitreal Aflibercept.
Blindbæk SL; Peto T; Grauslund J
Ophthalmic Res; 2020; 63(2):106-113. PubMed ID: 31715608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
